Last updated: August 21, 2025
Introduction
Patent KR102026321 pertains to a pharmaceutical invention filed in South Korea, with a focus on specific formulations or therapeutic methods. Understanding the scope, claims, and overall patent landscape surrounding this patent is essential for pharmaceutical companies, legal practitioners, and R&D entities aiming to navigate patent rights in South Korea’s dynamic pharmaceutical sector.
Patent Overview
KR102026321 was granted on March 23, 2021, by the Korean Intellectual Property Office (KIPO). The patent holders are likely a pharmaceutical corporation involved in the development of novel drug formulations or methods. Public patent databases indicate that the patent claims a substance, composition, or method designed to improve therapeutic efficacy, stability, or patient compliance.
Scope of the Patent
1. Technical Field
The patent relates to pharmaceutical compositions, specifically a drug formulation comprising active pharmaceutical ingredients (APIs), excipients, and scaffolding agents that enhance drug delivery or stability. It may cover solid, semi-solid, or liquid forms designed for oral or injectable administration.
2. Core Innovations
The scope encompasses:
- Novel Compound or Composition: A specific chemical entity or a mixture with enhanced bioavailability or reduced side effects.
- Method of Production: A unique process for synthesizing or preparing the drug, emphasizing efficiency or purity.
- Therapeutic Use: Application of the compound or composition for treating particular diseases such as cancer, infectious diseases, or metabolic disorders.
3. Territorial Coverage
The patent is valid in South Korea and could serve as a basis for regional patent strategy, blocking competitors from manufacturing or selling the claimed invention within South Korea.
Claims Analysis
1. Claim Structure
The patent includes independent claims defining the broadest scope of protection, supported by multiple dependent claims narrowing down specific aspects such as dosage, formulation, or synthesis parameters.
2. Key Elements of Claims
- Chemical Structure: The claims specify a chemical scaffold with particular substituents or stereochemistry critical for activity.
- Pharmacological Effect: Claims specify that the composition exhibits a specific therapeutic effect, such as inhibiting a target enzyme or receptor.
- Formulation Details: Claims may encompass particular excipients, stability-enhancing agents, or delivery systems.
- Method Claims: Steps for preparing the composition or method for managing or diagnosing a disease.
3. Claim Language and Limitations
The claims are carefully drafted to balance breadth and specificity, avoiding undue ambiguity while covering potential variations. This includes:
- Use of Markush structures to encompass various chemical derivatives.
- Inclusion of methodology claims to prevent easy workaround.
- Claims are often structured to cover both the composition and its uses, aligning with standard patent practices in pharmaceuticals.
4. Potential for Patent Challenges
Given the broad language typical of pharmaceutical patents, competitors may challenge the validity based on prior art references, especially if similar compounds or formulations exist.
Patent Landscape in South Korea
1. Related Patents and Patent Families
The patent landscape reveals several related patents filed prior to or following KR102026321, encompassing:
- Prior Art or Related Technologies: Earlier patents on similar chemical scaffolds, formulations, or therapeutic methods.
- Patent Family Members: Corresponding filings in the US, Europe, China, and Japan, indicating global patent strategies.
2. Competitive Players
Major South Korean pharmaceutical firms such as Hanmi Pharmaceutical, Celltrion, and LG Chem are active in the peptide, biologics, and chemical drug spaces, with several patents in similar fields. International companies like Pfizer or Novartis may also hold overlapping patents, underscoring the importance of patent clearance and freedom-to-operate analyses.
3. Patent Litigation and Settlements
No recent public records suggest litigation directly involving KR102026321. However, ongoing patenting in the same field underscores the competitive landscape.
4. Trends & Innovation Focus
Recent filings show an emphasis on biologics, targeted therapies, and delivery systems, indicating ascending innovation trajectories in South Korea's pharmaceutical patent space aligning with global trends.
Strategic Implications
1. Patent Valuation
KR102026321 offers enforceable rights within South Korea, valuable for exclusivity in the local market, especially for high-demand therapeutics or specialty formulations.
2. Opportunities & Risks
- Opportunities: Licensing, collaborations, or further development based on the patent claims.
- Risks: Potential patent infringement suits or invalidation based on prior art, emphasizing rigorous freedom-to-operate assessments.
3. Future Patent Strategies
Companies should monitor related patent filings, especially for improvements or second-generation products, to maintain a strong patent portfolio and defend their market position.
Conclusion
KR102026321 exemplifies South Korea’s robust patent environment for pharmaceutical innovations. Its claims potentially cover a significant chemical or formulation innovation with therapeutic benefits, strategically positioning the patent holder within the domestic market. Understanding its scope and claims is critical for formulation development, patent invalidity assessments, and competitive positioning.
Key Takeaways
- Comprehensive Claim Scope: The patent’s claims likely protect a specific chemical entity or formulation with defined therapeutic use, offering strong market exclusivity.
- Patent Landscape Complexity: The South Korean pharmaceutical patent space is highly active, with overlapping patents requiring careful analysis for freedom-to-operate.
- Strategic Value: KR102026321 provides a platform for further R&D, licensing, or collaborations within South Korea’s thriving biotech sector.
- Legal and Commercial Vigilance: Vigilance is necessary to monitor potential patent challenges or infringements, especially given the extensive patenting activity in related fields.
- Global Strategy Alignment: The patent’s family members and related filings indicate a broader international patent strategy, pivotal for global commercialization.
FAQs
1. What is the main innovation claimed in KR102026321?
The patent claims a novel pharmaceutical composition or method with enhanced therapeutic efficacy, possibly involving specific chemical structures or delivery systems designed for targeted treatment.
2. How does KR102026321 fit within South Korea’s patent landscape?
It contributes to an active portfolio of pharmaceutical patents in South Korea, aligned with regional innovation efforts focusing on biologics, chemical drugs, and delivery platforms.
3. Can this patent impact generic drug development in South Korea?
Yes, as it grants exclusivity rights, it can limit generic manufacturers’ ability to produce similar formulations or use similar methods without licensing or design-arounds.
4. Are there any notable patent family members associated with KR102026321?
While specific family members depend on filing globally, similar or related patents may exist in jurisdictions like the US, China, or Europe, reinforcing the patent strategy.
5. What should R&D entities consider when designing around this patent?
They should analyze the claims’ scope, identify potential design-around options, and consider advancing novel modifications or alternative mechanisms within legal boundaries.
Sources
[1] Korean Intellectual Property Office (KIPO) Patent Database
[2] WIPO Patent Statistical Database (PATSTAT)
[3] PatentScope – WIPO Public Patent Database
